Search

everythinglearnresearchcommunity

for

Search:↓

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

These new skin treatments are safer and more effective with minimal side effects.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

EGFR inhibitors for lung cancer can cause severe skin issues.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Tofacitinib helped a woman regrow hair with no major side effects.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

M50054 may help treat hepatitis and hair loss from chemotherapy.